A citation-based method for searching scientific literature

Anne S Quante, Alice S Whittemore, Tom Shriver, John L Hopper, Konstantin Strauch, Mary Beth Terry. J Natl Cancer Inst 2015
Times Cited: 28







List of co-cited articles
169 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
693
67

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
39

Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.
Anne S Quante, Alice S Whittemore, Tom Shriver, Konstantin Strauch, Mary B Terry. Breast Cancer Res 2012
71
35

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener,[...]. CA Cancer J Clin 2007
35

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.
A C Antoniou, A P Cunningham, J Peto, D G Evans, F Lalloo, S A Narod, H A Risch, J E Eyfjord, J L Hopper, M C Southey,[...]. Br J Cancer 2008
318
32

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
537
28

The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer.
Esther M John, John L Hopper, Jeanne C Beck, Julia A Knight, Susan L Neuhausen, Ruby T Senie, Argyrios Ziogas, Irene L Andrulis, Hoda Anton-Culver, Norman Boyd,[...]. Breast Cancer Res 2004
235
25

Assessing women at high risk of breast cancer: a review of risk assessment models.
Eitan Amir, Orit C Freedman, Bostjan Seruga, D Gareth Evans. J Natl Cancer Inst 2010
269
25

BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface.
A J Lee, A P Cunningham, K B Kuchenbaecker, N Mavaddat, D F Easton, A C Antoniou. Br J Cancer 2014
138
25

Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre.
R J MacInnis, A Bickerstaffe, C Apicella, G S Dite, J G Dowty, K Aujard, K-A Phillips, P Weideman, A Lee, M B Terry,[...]. Br J Cancer 2013
32
21

The BOADICEA model of genetic susceptibility to breast and ovarian cancer.
A C Antoniou, P P D Pharoah, P Smith, D F Easton. Br J Cancer 2004
296
21

Validation studies for models projecting the risk of invasive and total breast cancer incidence.
J P Costantino, M H Gail, D Pee, S Anderson, C K Redmond, J Benichou, H S Wieand. J Natl Cancer Inst 1999
506
21

Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC).
Mary Beth Terry, Kelly-Anne Phillips, Mary B Daly, Esther M John, Irene L Andrulis, Saundra S Buys, David E Goldgar, Julia A Knight, Alice S Whittemore, Wendy K Chung,[...]. Int J Epidemiol 2016
38
21

Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC).
Sepideh Saadatmand, Inge-Marie Obdeijn, Emiel J Rutgers, Jan C Oosterwijk, Rob A Tollenaar, Gwendolyn H Woldringh, Elisabeth Bergers, Cornelis Verhoef, Eveline A Heijnsdijk, Maartje J Hooning,[...]. Int J Cancer 2015
53
21

Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.
Adam R Brentnall, Jack Cuzick, Diana S M Buist, Erin J Aiello Bowles. JAMA Oncol 2018
90
21

Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme.
E Amir, D G Evans, A Shenton, F Lalloo, A Moran, C Boggis, M Wilson, A Howell. J Med Genet 2003
186
17

Prediction of breast cancer risk based on profiling with common genetic variants.
Nasim Mavaddat, Paul D P Pharoah, Kyriaki Michailidou, Jonathan Tyrer, Mark N Brook, Manjeet K Bolla, Qin Wang, Joe Dennis, Alison M Dunning, Mitul Shah,[...]. J Natl Cancer Inst 2015
320
17

Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging.
Ellen Warner, Kimberley Hill, Petrina Causer, Donald Plewes, Roberta Jong, Martin Yaffe, William D Foulkes, Parviz Ghadirian, Henry Lynch, Fergus Couch,[...]. J Clin Oncol 2011
165
17

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
B Fisher, J P Costantino, D L Wickerham, C K Redmond, M Kavanah, W M Cronin, V Vogel, A Robidoux, N Dimitrov, J Atkins,[...]. J Natl Cancer Inst 1998
17

Which risk model to use? Clinical implications of the ACS MRI screening guidelines.
Elissa M Ozanne, Brian Drohan, Phil Bosinoff, Alan Semine, Michael Jellinek, Claire Cronin, Frederick Millham, Dana Dowd, Taryn Rourke, Caroline Block,[...]. Cancer Epidemiol Biomarkers Prev 2013
46
17

BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research.
Susan L Neuhausen, Hilmi Ozcelik, Melissa C Southey, Esther M John, Andrew K Godwin, Wendy Chung, Jeniffer Iriondo-Perez, Alexander Miron, Regina M Santella, Alice Whittemore,[...]. Breast Cancer Res Treat 2009
46
14

Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort.
Kelly-Anne Phillips, Phyllis N Butow, Ailsa E Stewart, Jiun-Horng Chang, Prue C Weideman, Melanie A Price, Sue Anne McLachlan, Geoffrey J Lindeman, Michael J McKay, Michael L Friedlander,[...]. Fam Cancer 2005
46
14


Prospective breast cancer risk prediction model for women undergoing screening mammography.
William E Barlow, Emily White, Rachel Ballard-Barbash, Pamela M Vacek, Linda Titus-Ernstoff, Patricia A Carney, Jeffrey A Tice, Diana S M Buist, Berta M Geller, Robert Rosenberg,[...]. J Natl Cancer Inst 2006
286
14

Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline.
Kala Visvanathan, Patricia Hurley, Elissa Bantug, Powel Brown, Nananda F Col, Jack Cuzick, Nancy E Davidson, Andrea Decensi, Carol Fabian, Leslie Ford,[...]. J Clin Oncol 2013
207
14

Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014
510
14

Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial.
Jack Cuzick, Ivana Sestak, Simon Cawthorn, Hisham Hamed, Kaija Holli, Anthony Howell, John F Forbes. Lancet Oncol 2015
241
14

Exemestane for breast-cancer prevention in postmenopausal women.
Paul E Goss, James N Ingle, José E Alés-Martínez, Angela M Cheung, Rowan T Chlebowski, Jean Wactawski-Wende, Anne McTiernan, John Robbins, Karen C Johnson, Lisa W Martin,[...]. N Engl J Med 2011
574
14

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer.
Victor G Vogel, Joseph P Costantino, D Lawrence Wickerham, Walter M Cronin, Reena S Cecchini, James N Atkins, Therese B Bevers, Louis Fehrenbacher, Eduardo R Pajon, James L Wade,[...]. Cancer Prev Res (Phila) 2010
394
14

Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.
Fergus J Couch, Steven N Hart, Priyanka Sharma, Amanda Ewart Toland, Xianshu Wang, Penelope Miron, Janet E Olson, Andrew K Godwin, V Shane Pankratz, Curtis Olswold,[...]. J Clin Oncol 2015
393
14

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
14

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data.
Jack Cuzick, Ivana Sestak, Bernardo Bonanni, Joseph P Costantino, Steve Cummings, Andrea DeCensi, Mitch Dowsett, John F Forbes, Leslie Ford, Andrea Z LaCroix,[...]. Lancet 2013
277
14

Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer.
Ellen Warner, Hans Messersmith, Petrina Causer, Andrea Eisen, Rene Shumak, Donald Plewes. Ann Intern Med 2008
334
14

Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model.
Jeffrey A Tice, Steven R Cummings, Rebecca Smith-Bindman, Laura Ichikawa, William E Barlow, Karla Kerlikowske. Ann Intern Med 2008
349
14

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
Nasim Mavaddat, Kyriaki Michailidou, Joe Dennis, Michael Lush, Laura Fachal, Andrew Lee, Jonathan P Tyrer, Ting-Huei Chen, Qin Wang, Manjeet K Bolla,[...]. Am J Hum Genet 2019
317
14

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors.
Andrew Lee, Nasim Mavaddat, Amber N Wilcox, Alex P Cunningham, Tim Carver, Simon Hartley, Chantal Babb de Villiers, Angel Izquierdo, Jacques Simard, Marjanka K Schmidt,[...]. Genet Med 2019
177
14

10-year performance of four models of breast cancer risk: a validation study.
Mary Beth Terry, Yuyan Liao, Alice S Whittemore, Nicole Leoce, Richard Buchsbaum, Nur Zeinomar, Gillian S Dite, Wendy K Chung, Julia A Knight, Melissa C Southey,[...]. Lancet Oncol 2019
72
14


NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis.
Therese B Bevers, Benjamin O Anderson, Ermelinda Bonaccio, Saundra Buys, Mary B Daly, Peter J Dempsey, William B Farrar, Irving Fleming, Judy E Garber, Randall E Harris,[...]. J Natl Compr Canc Netw 2009
261
10


Large-scale genotyping identifies 41 new loci associated with breast cancer risk.
Kyriaki Michailidou, Per Hall, Anna Gonzalez-Neira, Maya Ghoussaini, Joe Dennis, Roger L Milne, Marjanka K Schmidt, Jenny Chang-Claude, Stig E Bojesen, Manjeet K Bolla,[...]. Nat Genet 2013
787
10

The contributions of breast density and common genetic variation to breast cancer risk.
Celine M Vachon, V Shane Pankratz, Christopher G Scott, Lothar Haeberle, Elad Ziv, Matthew R Jensen, Kathleen R Brandt, Dana H Whaley, Janet E Olson, Katharina Heusinger,[...]. J Natl Cancer Inst 2015
119
10

Breast cancer risk prediction accuracy in Jewish Israeli high-risk women using the BOADICEA and IBIS risk models.
Yael Laitman, Monica Simeonov, Lital Keinan-Boker, Irena Liphshitz, Eitan Friedman. Genet Res (Camb) 2013
10
30

Performance of common genetic variants in breast-cancer risk models.
Sholom Wacholder, Patricia Hartge, Ross Prentice, Montserrat Garcia-Closas, Heather Spencer Feigelson, W Ryan Diver, Michael J Thun, David G Cox, Susan E Hankinson, Peter Kraft,[...]. N Engl J Med 2010
324
10

Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density.
Jinbo Chen, David Pee, Rajeev Ayyagari, Barry Graubard, Catherine Schairer, Celia Byrne, Jacques Benichou, Mitchell H Gail. J Natl Cancer Inst 2006
240
10

Online tool to guide decisions for BRCA1/2 mutation carriers.
Allison W Kurian, Diego F Munoz, Peter Rust, Elizabeth A Schackmann, Michael Smith, Lauren Clarke, Meredith A Mills, Sylvia K Plevritis. J Clin Oncol 2012
57
10

ACR Appropriateness Criteria Breast Cancer Screening.
Martha B Mainiero, Ana Lourenco, Mary C Mahoney, Mary S Newell, Lisa Bailey, Lora D Barke, Carl D'Orsi, Jennifer A Harvey, Mary K Hayes, Phan Tuong Huynh,[...]. J Am Coll Radiol 2013
112
10

Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics.
A C Antoniou, R Hardy, L Walker, D G Evans, A Shenton, R Eeles, S Shanley, G Pichert, L Izatt, S Rose,[...]. J Med Genet 2008
129
10

Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Nadine Tung, Chiara Battelli, Brian Allen, Rajesh Kaldate, Satish Bhatnagar, Karla Bowles, Kirsten Timms, Judy E Garber, Christina Herold, Leif Ellisen,[...]. Cancer 2015
280
10

Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined.
Eveline A M Heijnsdijk, Ellen Warner, Fiona J Gilbert, Madeleine M A Tilanus-Linthorst, Gareth Evans, Petrina A Causer, Rosalind A Eeles, Reinie Kaas, Gerrit Draisma, Elizabeth A Ramsay,[...]. Cancer Epidemiol Biomarkers Prev 2012
54
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.